Core Viewpoint - The company, Hainan Huayan Collagen Technology Co., Ltd., has developed a method to utilize fish processing by-products, such as fish scales and skins, to produce high-value collagen peptides through enzymatic hydrolysis technology, addressing resource waste and environmental pressure in the seafood processing industry [1][2]. Group 1: Company Development and Innovation - The company has been focused on the development and utilization of marine biological resources for 20 years, achieving significant technological breakthroughs and international expansion, with products sold in over 50 countries [1][2]. - Hainan Huayan has established a world-leading marine biological peptide innovation base and has been recognized as a national high-tech enterprise [1][2]. - The company has invested 8% to 10% of its annual revenue into research and development, emphasizing the importance of enhancing its innovation capabilities for sustainable growth [5]. Group 2: Technological Advancements - The company has successfully developed a core technology for controlling biological active enzymes, which is crucial for extracting specific molecular weight peptide products [3]. - After two and a half years of research and nearly 3,000 experiments, the company achieved a breakthrough in producing a new product, cyclic dipeptide, and obtained two national patents [3]. - Collaborative research with various scientific institutions has led to significant improvements in extraction rates and product purity, achieving internationally leading technology levels [4][5]. Group 3: Market Expansion - Hainan Huayan is strategically expanding its production capacity and market presence, with plans to establish production bases in multiple locations, including Hainan and Henan, and sales centers in major cities [6]. - The company has invested in a fish collagen peptide industrialization base in Haikou, which is now the largest facility for producing marine biological peptide monomers in Asia, with an annual production capacity of 4,500 tons [6]. - A joint venture has been established in Thailand to operate a tuna peptide processing plant, marking an important step in the company's international development [6]. Group 4: Future Goals - The company aims to continuously focus on high-value utilization of marine biological resources, functional product technology research, and international market expansion, with a goal to launch 2 to 3 innovative products annually and become a leading platform for functional peptide raw material research and manufacturing by 2027 [7].